Sanofi vaccine sales face headwinds from US policy shifts

By Bhanvi Satija LONDON, Jan 29 (Reuters) - France's Sanofi, among the world's largest vaccine makers, said on Thursday that its vaccines sales would be "slightly negative" this year, partly due to U.S. policy changes under ​President Donald Trump. Sanofi is eyeing high-single-digit overall sales growth in 2026. But vaccines will remain a weak spot ‌in the United States where Health Secretary Robert F. Kennedy Jr., a longtime anti-vaccine activist, has upended official recommendations in the past year. ...